Related Experiment Video
Updated: Jul 18, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Optimization of cardiac troponin I pull-down by IDM affinity beads and SELDI
Diane E Bovenkamp1, Brian A Stanley, Jennifer E Van Eyk
1Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Insights
This study optimizes methods for detecting modified cardiac troponin I (cTnI) in serum. Improved enrichment and detection techniques enhance diagnostic accuracy for acute myocardial injury by identifying protein modifications.
Area of Science:
- Biochemistry
- Proteomics
- Cardiovascular Medicine
Background:
- Cardiac troponin I (cTnI) is a crucial regulator of cardiac muscle contraction and a biomarker for myocardial injury.
- Current diagnostic methods using enzyme-linked immunosorbent assays often miss critical post-translational modifications of cTnI.
- Identifying modified cTnI forms in serum or biopsies can provide more specific diagnoses for acute myocardial injury.
Purpose of the Study:
- To optimize enrichment and detection methods for cardiac troponin I (cTnI) and its modified forms.
- To improve proteomic analysis of cTnI in cardiac and serum tissues.
- To enhance the specificity of diagnosing acute myocardial injury through modified cTnI detection.
Main Methods:
- Utilized IDM Affinity Bead pull-down for cTnI enrichment.
- Employed surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) for detection.
- Adjusted buffer chemical compositions to maintain antibody specificity and enrich for cTnI variants.
Main Results:
- Successfully optimized enrichment and detection protocols for cTnI.
- Demonstrated the ability to enrich for various forms of cTnI and associated proteins.
- Maintained antibody specificity throughout the enrichment process.
Conclusions:
- Optimized IDM Affinity Bead pull-down and SELDI-TOF-MS offer improved detection of modified cTnI.
- These enhanced methods can identify disease-specific cTnI modifications for more accurate diagnoses.
- This approach advances proteomic analysis of cTnI in clinical diagnostics.
Abstract:
Cardiac troponin I (cTnI) is a key regulator of cardiac muscle contraction. Upon myocardial cell injury, cTnI is lost from the cardiac myocyte and can be detected in serum, in some cases with specific disease-induced modifications, making it an important diagnostic marker for acute myocardial injury. Presently, hospital laboratories use enzyme-linked immunosorbent assays to detect cTnI, but this type of analysis lacks information about modified forms of protein (degradation or phosphorylation) that may give a more specific diagnosis from either serum or biopsies. Because cardiac and serum tissues are widely used for proteomic analysis, it is important to detect these cTnI posttranslational modifications. Therefore, we have chosen to optimize the enrichment and detection of cTnI protein by IDM Affinity Bead pull-down and surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS or SELDI) analyses. By adjusting the chemical compositions of the buffers, we have retained antibody specificity and enriched for different forms of cTnI and its associated proteins.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
12:11Simultaneous Affinity Enrichment of Two Post-Translational Modifications for Quantification and Site Localization
Published on: February 27, 2020